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Abstract The sarcoplasmic reticulum-bound creatine kinase 
from rabbit skeletal muscle was inhibited by the nitric oxide 
donor S-nitrosoglutathione (GSNO). This led to a decrease in 
Ca 2÷ uptake in sarcoplasmic reticulum vesicles when the 
transport was driven by ATP generated from phosphocreatine 
and ADP. In contrast, the Ca 2÷ transport measured using 2 mM 
ATP as substrate was unaffected by GSNO up to 200 IxlVl. 
GSNO (5--20 lEVI) inhibited the activity of both soluble and 
membrane-bound creatine kinase. Oxyhemoglobin (15-40 lEVI) 
protected creatine kinase against inactivation by GSNO. The 
inhibition by 10 ~M GSNO was reversed by the addition of 
dithiothreitol (2 raM). The results indicate that nitric oxide (NO, 
including NO +, NO and NO-)  inactivates creatine kinase in 
vitro by promoting nitrosylation of critical sulphydryl groups of 
the enzyme. 
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1. Introduction 
Nitric oxide is an intercellular messenger molecule that is 
synthesized from L-arginine in several tissues by a reaction 
catalyzed by NO synthases [1]. Different enzymes involved 
in energy transduction are inhibited by NO. These include 
glyceraldehyde-3-phosphate dehydrogenase, aconitase and 
complex I and II of the respiratory chain [1]. Skeletal muscle 
expresses high levels of neuronal type NO synthase [2]. Re- 
cently, it has been proposed that NO could affect skeletal 
muscle via two different mechanisms. One is related to activa- 
t ion of guanylyl cyclase which decreases the force generation 
by skeletal muscle fibers [3]. The other involves a possible S- 
nitrosylation of thiol groups in the sarcoplasmic reticulum 
such as those from the Ca 2+ pump [3]. In the present report, 
we investigate whether NO donors affect the Ca 2+ transport  
of sarcoplasmic reticulum. 
2. Materials and methods 
2.1. Vesicle preparation 
Sarcoplasmic reticulum vesicles were prepared from rabbit fast skel- 
etal muscle as described [4]. 
2.2. Ca 2+ uptake 
Ca 2+ uptake was measured by filtration through Millipore filters 
*Corresponding author. Fax: (55) (21) 270 86 47. 
Abbreviations: dcGMP, N2,O3'-dibutyrylguanosine Y,5'-cyclic mono- 
phosphoric acid; DTT, dithiothreitol; GAPDH, glyceraldehyde-3- 
phosphate dehydrogenase; GSNO, S-nitrosoglutathione; Mops, 4- 
morpholinopropanesulfonic ac d; NO, nitric oxide (including NO +, 
NO and NO-);  SNAP, S-nitroso N-acetylpenicillamine. 
(0.45 ~tm). The filter was washed six times with 5 ml of 3 mM 
La(NO3)3 and the remaining radioactivity was determined in a scin- 
tillation counter. 
2.3. Creatine kinase activity 
MM-creatine kinase (Sigma) or sarcoplasmic reticulum vesicles 
were incubated in the presence of various concentrations of GSNO, 
50 mM MOPS-Tris (pH 7.0), 5 mM MgC12, 100 mM KC1 and diluted 
10-fold in a medium containing 50 mM MOPS-Tris (pH 7.0), 5 mM 
MgCI2, 100 mM KC1, 10 mM phosphocreatine, 1 mM ADP, 1 mM 
NAD ÷, 20 mM glucose, 2 U/ml hexokinase (Sigma), 2 U/ml glucose- 
6-phosphate dehydrogenase (Sigma) and 10 p.M APsA. The forward 
reaction of creatine kinase was measured by NADH formation mon- 
itored by changes in absorbance at 340 nm. The NO donors in the 
concentration range used in this study had no effect on hexokinase or 
glucose-6-phosphate dehydrogenase activity measured by direct addi- 
tion of ATP to the cuvette. 
2.4. GAPDH activity 
Purified GAPDH (1 U/ml, Boehringer Mannheim) was incubated in 
either the absence or presence of various GSNO concentrations in a 
medium with the same composition as that described for creatine 
kinase. After 2 min the enzyme was diluted 5-fold in a medium con- 
taining 100 mM HEPES-Tris (pH 7.7), 1 mM ATP, 0.9 mM EDTA, 
2 mM MgSO4, 6 mM 3-phosphoglyceric acid, 0.2 mM NADH and 10 
U/ml 3-phosphoglycerate kinase (Boehringer Mannheim). NADH 
consumption was monitored at 340 nm. 
2.5. Reagents 
SNAP and GSNO were gifts from Dr. J. Assreuy (Department of 
Pharmacology, Federal University of Rio de Janeiro). Oxy- and 
methemoglobin were prepared according to Martin et al. [5]. 
3. Results 
The Ca 2+ pump is a membrane-bound protein that pumps 
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Fig. 1. Effect of GSNO on Ca 2+ uptake in sarcoplasmic reticulum 
vesicles. Vesicles were incubated for 20 min in order to ensure ade- 
quate release of NO in a medium containing 50 mM MOPS-Tris 
(pH 7.0), 100 mM KCI, 20 mM Pi, 0.02~0.05 mg vesicle protein/ml, 
10 ~tM APsA, in the absence (©) or presence of 200 p.M GSNO 
(e), or 1 mM dcGMP (zx). Ca 2+ uptake was started by the addi- 
tion of either 2 mM ATP (A) or 10 mM phosphocreatine plus 
1 mM ADP (B). The values are representative of 34  experiments 
with two different vesicle preparations. 
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Fig. 2. Protection by oxyhemoglobin against inhibition of Ca ~+ up- 
take by GSNO. Ca 2+ uptake was measured as described in the leg- 
end to Fig. 1, using 1 mM ADP and 10 mM phosphocreatine to
load the vesicles in the presence of various GSNO concentrations, 
in either the absence (O) or presence of 40 ktM oxyhemoglobin (e). 
The reaction was stopped after 10 min as described in Section 2. 
100% Ca 2+ uptake corresponded to 1.5 lamol Ca2+/mg vesicle pro- 
tein. The values are representative of three experiments with two 
different vesicle preparations. 
Ca 2+ from the cytosol to the lumen of sarcoplasmic reticulum 
using the energy derived from ATP hydrolysis [6]. GSNO, up 
to 200 ~tM had no effect on Ca z+ uptake in sarcoplasmic 
reticulum vesicles when a high ATP concentration (2 mM) 
was used as substrate (Fig. 1A). It has been shown that sar- 
coplasmic reticulum vesicles retain a membrane-bound crea- 
tine kinase that supports local ATP regeneration [7,8]. Thus, 
in the presence of phosphocreatine plus ADP, the Ca2+-AT - 
Pase pumps Ca 2+ using the ATP generated at the surface of 
the membrane by the creatine kinase (Fig. 1B). We found that 
GSNO inhibited Ca 2+ uptake when ADP and phosphocrea- 
tine were present in the medium (Fig. 1B). Half-maximal in- 
hibition was achieved at 10 IxM GSNO (Fig. 2). The Ca 2+ 
uptake measured using the ATP synthesized by other ATP 
regenerating systems, such as pyruvate kinase and adenylate 
kinase, was not affected by GSNO up to a concentration of 
200 ~tM (data not shown). Thus, in the experiments in Figs. 1 
and 2, APsA (10 p.M) was added to the assay medium in 
order to prevent he synthesis of ATP from ADP catalyzed 
by adenylate kinase activity. The effect of GSNO in sarcoplas- 
mic reticulum vesicles was not due to peroxynitrite formation, 
since the addition of superoxide dismutase (50 U/ml) did not 
abolish the effect of GSNO (data not shown). In addition, 
dcGMP (1 mM) had no effect (Fig. 1), indicating that the 
effects observed in the present study are not mediated by 
activation of guanylyl cyclase and production of cGMP. Oxy- 
hemoglobin, which binds NO with high affinity, prevented 
inhibition when added to the medium prior to GSNO (Fig. 
2). These results indicate that the effects observed are 
mediated by NO itself, and not by a non-specific effect of 
the NO donors. 
GSNO inhibits the activity of both the purified (Fig. 3A) 
and the sarcoplasmic reticulum-bound creatine kinase (data 
not shown). Even though the incubation time used was only 
2 min, 10 ~tM GSNO promoted almost total inhibition of 
purified creatine kinase activity. Under similar conditions, 
half-maximal inhibition of GAPDH activity was attained at 
40 ~tM GSNO (data not shown). As observed for Ca 2+ up- 
take, oxyhemoglobin protected the enzyme against inactiva- 
tion by GSNO (Fig. 3A). The half-life of GSNO is in the 
range of several hour to days and the product of NO release 
is the thiol disulphide GSSG [9]. In control experiments it was 
observed that the addition of 10 txM of a 1-week-old solution 
of GSNO had no effect on creatine kinase activity (data not 
shown). Another NO donor, SNAP (100-500 p.M) also inhib- 
ited creatine kinase activity and Ca 2+ uptake (data not 
shown). DTT (2 mM) was able to reverse the inhibition of 
both purified creatine kinase (Fig. 3B) and Ca 2+ uptake (data 
not shown). Under the same conditions, but without NO do- 
nors, DTT had no effect on creatine kinase activity (not 
shown). These results indicate that the mechanism of NO 
inhibition is mediated by nitrosylation of critical SH groups 
of creatine kinase. 
4. Discussion 
GSNO used in the present study has been found endogen- 
ously in neutrophils and human airways at micromolar con- 
centrations [10,11]. Several effects of NO are not mediated by 
guanylyl cyclase activation. NO (in the NO + and NO-  forms) 
has high affinity for sulphydryl groups and promote S-nitro- 
sylation of numerous proteins [9]. On this basis, it has been 
postulated that NO may affect Ca z+ fluxes in the sarcoplasmic 
reticulum [3]. We now show that the sarcoplasmic reticulum 
Ca2+-ATPase is not directly inhibited by NO (Fig. 1). Ca 2+ 
transport, however, may be indirectly affected by the inhibi- 
tion of local ATP regeneration by creatine kinase. 
Creatine kinase plays a crucial role in the process of energy 
transduction and occurs both in the soluble cytoplasmic com- 
partment and bound to subcellular organelles uch as mito- 
chondria, myofilaments and endoplasmic reticulum [7,8,12- 
14]. Creatine kinase possesses 8 sulphydryl groups, and several 
sulphydryl reagents inhibit the enzyme activity [15]. However, 
not all sulphydryl reagents are able to inactivate the enzyme, 
suggesting that the cysteines may not be essential for catalysis 
[15]. In order to explain this apparent discrepancy, Hou and 
Vollmer [16] proposed that creatine kinase is able to regener- 
ate free thiol at the active site. The reversal of inhibition by 
NO after the addition of DTT suggests that the inhibition 
involves S-nitrosylation of critical sulphydryl groups of the 
enzyme. Similar to that observed with GAPDH, creatine ki- 
nase was inhibited by GSNO concentrations which are likely 
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Fig. 3. Inhibition of purified creatine kinase by GSNO. Protection 
by oxyhemoglobin (A) and by DTT (B). Creatine kinase activity 
was measured as described in Section 2. (A) Purified creatine kinase 
(1 U/ml) was incubated for 2 min in the presence of various concen- 
trations of GSNO, in either the absence (O) or presence of 15 ~tM 
oxyhemoglobin (e). (B) After inhibition of creatine kinase was es- 
tablished by preincubation for 2 min in the presence of 500 IxM 
GSNO, DTT was added to the cuvette to a final concentration of 
1 mM (e) as indicated by the arrow. The values are representative 
of 4 experiments. 
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to be found in vivo [10,11]. This implies that creatine kinase is 
a potential target for NO. 
It has been shown that NO inhibits energy-generating path- 
ways and decreases ATP levels in synaptosomes [17]. It is 
noteworthy that mistargeting of NO synthase from the sarco- 
lemma to the cytoskeleton may be involved in pathological 
states such as muscle dystrophy [18]. In such conditions, NO 
may exert inhibition of key enzymes at unwanted sites. This 
finding and those shown in the present report led us to hy- 
pothesize that the inhibition of creatine kinase by NO might 
be involved in mechanisms of cell injury. 
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